Vimarsana
Biggest News Aggregation in the World

Page 9 - Pharma Intelligence Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharma Intelligence Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharma Intelligence Center Today - Breaking & Trending Today

Indian home-grown COVID-19 shot wins WHO emergency use approval - Vimarsana News

Indian home-grown COVID-19 shot wins WHO emergency use approval

The World Health Organization (WHO) said on Wednesday that it has granted approval for Indian drugmaker Bharat Biotech's home-grown COVID-19 vaccine for emergency use listing, paving the way for it to be accepted as a valid vaccine in many poor countries.

Malignant Mesothelioma - Competitive Landscape in 2021 - Vimarsana News

Malignant Mesothelioma - Competitive Landscape in 2021

New York, June 11, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Malignant Mesothelioma - Competitive Landscape in ...

April 2021 CDMO Opportunities And Threats Report - Vimarsana News

April 2021 CDMO Opportunities And Threats Report

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities...

Roche leads industry sponsored oncology trials in Australia, says GlobalData - Vimarsana News

Roche leads industry sponsored oncology trials in Australia, says GlobalData

Search jobs Roche leads industry sponsored oncology trials in Australia, says GlobalData Australia has the highest age-standardized incidence rate for all cancers in the world and one of the countries with substantial cancer screening programs. Against this backdrop, several pharma companies are conducting clinical trials related to cancer drugs in the country. Among these, Roche continues to be a key player with the highest number of clinical trials in oncology indications, says GlobalData, a leading data and analytics company.   Ms. Sasmitha Sahu, Pharma Analyst a...

CAR-T therapy leads Singapore medical tourism within APAC - Vimarsana News

CAR-T therapy leads Singapore medical tourism within APAC

CAR-T therapy leads Singapore medical tourism within APAC 12 April 2021 | Analysis With the approval of Novartis’ Kymriah, Singapore is becoming a popular medical tourism destination within APAC: says GlobalData Photo Credit: GlobalData The inherent heterogeneity of diseases such as cancer is driving the field of personalized (precision) therapies. Within personalized therapies, chimeric antigen receptor (CAR-T) therapies are gaining traction. With the approval of Novartis’ Kymriah, Singapore is now all set to deliver the transformative treatment for cancers and takes the lea...